Immuni T is proud to announce that we have been recognized by the Standards Council of Canada (SCC) as being compliant with the OECD Principles of Good Laboratory Practice (GLP). GLP regulates the conduct of all non-clinical safety studies worldwide; the SCC is the only monitoring body that grants GLP recognition in Canada.
GLP recognition means that Immuni T has the infrastructure, personnel, and knowledge to conduct studies that produce valid and high quality data intended for submission to Health Canada, the US FDA, and regulatory bodies around the world (IND or CTA). In the drug development process, these bodies use this data to decide whether clinical studies in humans can proceed.
Immuni T develops, validates, and executes GLP-compliant toxicity, anti-drug antibody (ADA), and other assays, to support non-clinical safety studies.
Immuni T is a Montreal-based contract research organization (CRO) that offers immunology services on flow cytometry, ligand binding, and cell-based platforms.
To learn more about Immuni T's GLP services, contact us at firstname.lastname@example.org or +1-514-545-3097 extension 102.